FDA.reportPublic FDA data

BRIMONIDINE TARTRATE

Substance profile for UNII 4S9CL2DY2H, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for BRIMONIDINE TARTRATE
Structure render from PubChem CID 54405

Substance Identity#

UNII
4S9CL2DY2H
Preferred term
BRIMONIDINE TARTRATE
Registry number
70359-46-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C11H10BrN5.C4H6O6
Chemical structure for BRIMONIDINE TARTRATE
Structure render from PubChem CID 54405

Chemical And Database Identifiers#

InChIKey
QZHBYNSSDLTCRG-LREBCSMRSA-N
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3
RxCUI
39171
PubChem
54405
NCIt
C47419
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound54405https://pubchem.ncbi.nlm.nih.gov/compound/54405
PubChem InChIKey SearchQZHBYNSSDLTCRG-LREBCSMRSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=QZHBYNSSDLTCRG-LREBCSMRSA-N
RxNorm39171https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=39171
NCI ThesaurusC47419https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47419
FDA Substance Registration System4S9CL2DY2Hhttps://precision.fda.gov/uniisearch/srs/unii/4S9CL2DY2H

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
brimonidine tartrateACTIVE INGREDIENT4S9CL2DY2HThese highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 19964
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBrimonidine Tartrate Ophthalmic Solution 0.2% (Sterile)2
brimonidine tartrateACTIVE INGREDIENT4S9CL2DY2HThese highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 20071
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2H6b660d4c-5df1-4f38-a0c3-82fd1353faa74
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2Hbc1785c5-1448-4791-9868-2fbbc8703b3b1
brimonidine tartrateACTIVE INGREDIENT4S9CL2DY2HALPHAGAN P (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [ALLERGAN, INC. ]10
brimonidine tartrateACTIVE INGREDIENT4S9CL2DY2HCOMBIGAN (BRIMONIDINE TARTRATE, TIMOLOL MALEATE) SOLUTION/ DROPS [ALLERGAN, INC.]9
Brimonidine TartrateACTIVE INGREDIENT4S9CL2DY2HSIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TARTRATE) SUSPENSION/ DROPS [ALCON LABORATORIES, INC.]8
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION [SANDOZ INC]7
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION/ DROPS [OSMOTICA PHARMACEUTICAL CORP.]7
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HMIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.]6
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]5
brimonidine tartrateACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION/ DROPS [PACIFIC PHARMA, INC.]4
Brimonidine TartrateACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [AKORN, INC.]3
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.2% SOLUTION/ DROPS [WESTMINSTER PHARMACEUTICALS, LLC]3
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION [SANDOZ INC]2
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION/ DROPS [REMEDYREPACK INC. ]1
BRIMONIDINE TARTRATEACTIVE INGREDIENT4S9CL2DY2HBRIMONIDINE TARTRATE SOLUTION/ DROPS [REMEDYREPACK INC. ]1